Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Spectral Medical Inc.TSX: EDT.TO

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 14.9% from a year ago

Cash & equivalents stood at CA$1.92M at the end of Q1 FY2026, up 14.9% from a year earlier and down 52.9% from the prior quarter. Over 3 fiscal years it compounded at -21.5% a year.

Context

  • Cash & equivalents amounted to 41.9% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +14.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.92M-52.9% QoQ
Last fiscal yearDec 2025
CA$4.07M+36.2% YoY
Year agoMar 2025
CA$1.67M+14.9% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+14.9%——
1 year+36.2%——
3-year CAGR-21.5%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

CAD · from the balance sheet

Latest · FY2025
4.07M CAD
Year-over-year change
+36.2%
4-year CAGR
-17.7%

Cash & Equivalents vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +14.9% is the 4th highest of 8, against a peer median of +8.4%.
  • Cash & equivalents amounts to 41.9% of total assets for EDT.TO, versus a peer median of 37.2%.
EDT.TO Competitors
Cash & Equivalents for EDT.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WEED.TOCanopy Growth CorporationMar 2026CA$364.68M CAD+220.4%-18.6%32.6%
ACB.TOAurora Cannabis Inc.Mar 2026CA$112.48M CAD-18.4%-28.0%18.7%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$58.54M USD+113.2%+48.1%40.2%
KSI.TOKneat.com, Inc.Mar 2026CA$51.52M CAD-30.5%+58.3%37.2%
PRN.TOProfound Medical Corp.Mar 2026$50.33M USD+8.4%+8.6%68.5%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$40.08M USD+76.7%+15.6%55.9%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$6.41M USD-70.8%-36.2%4.2%
EDT.TOSpectral Medical Inc.Mar 2026CA$1.92M CAD+14.9%-21.5%41.9%
Peer median (excluding EDT.TO) —+8.4%+8.6%37.2%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents8.89M8.41M2.95M2.99M4.07M
Short-term Investments00000
Net Receivables205K1.06M186K451K205K
Inventory293K340K366K229K377K
Other Current Assets875K192K135K00
Total Current Assets10.26M10.09M4.13M4.46M5.29M
Property, Plant & Equipment (Net)1.06M701K893K687K474K
Goodwill00000
Intangible Assets228K211K193K175K333K
Long-term Investments0998K000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets1.29M1.91M1.09M862K807K
Total Assets11.56M12M5.21M5.32M6.1M
Account Payables444K1.65M1.6M990K1.34M
Short-term Debt03.57M264K14.43M16.44M
Tax Payables00000
Deferred Revenue689K696K727K380K693K
Other Current Liabilities602K337K7.19M9.74M47.37M
Total Current Liabilities2.3M6.63M10.24M27.45M66.27M
Long-term Debt03.49M7.68M04.29M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)4.68M4.01M3.34M5.05M4.56M
Other Non-current Liabilities0000470K
Total Non-current Liabilities5.17M7.92M11.52M5.42M9.55M
Total Liabilities7.47M14.55M21.76M32.87M75.82M
Common Stock84.36M87.05M87.06M90.57M95.93M
Retained Earnings(98.49M)(109.78M)(125.44M)(140.84M)(188.53M)
Accumulated OCI10.24M11.4M12.91M12.58M12.66M
Other Stockholders Equity00100
Minority Interest00000
Total Equity4.08M(2.55M)(16.55M)(27.55M)(69.72M)
Total Debt582K7.57M8.56M14.93M21.09M
Net Debt(8.31M)(1.77M)5.61M11.94M17.02M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.